| SKU | ISG010302 |
| Brand | موزانجليك |
| Categories | Feminine Personal Care |
| Color | black |
| Shop by Concerns | Irregular Periods |
| Gender | Female |
| Shop By Goals | Contraception |
| Imported Or Local | Local |
| Ingredient | Drospirenone ethinyl estradiol |
| Specialty | Clinically Tested Hormonal Contraception Prescription only |
| Sub Categories | Pregnancy & Ovulation Tests |
| Warning | Consult doctor if you have liver disease Does Not Protect Against STIs or HIV hypertension Increased risk of blood clots May cause migraine Not for use in case of pregnancy or breastfeeding or diabetes Use with caution in older adults or smokers |
Mozanglic Drospirenone 3 Mg + Ethinylestradiol 0.03 Mg
Description:
Mozanglic 0.03/3 mg 21 tablets is a combined oral contraceptive pill (COC) containing drospirenone and ethinyl estradiol. It is a prescription hormonal medicine used primarily for contraception to prevent pregnancy. Each tablet combines a synthetic progestin (drospirenone) with a synthetic estrogen (ethinyl estradiol) to inhibit ovulation and induce changes in the cervical mucus and endometrium, providing reliable birth control when taken correctly. This product is intended for women of reproductive age under medical supervision.
Indications:
- Hormonal contraception for women of reproductive age to prevent pregnancy.
- Helps regulate menstrual cycles in women using it for contraception.
- May reduce menstrual pain (dysmenorrhea) and menstrual blood loss in women taking it as a contraceptive (as assessed by the prescribing physician).
- May improve acne and seborrhea in some women using drospirenone/ethinyl estradiol combinations, when prescribed by a doctor for this purpose.
Active Ingredients / Key Components:
- Drospirenone – 3 mg per tablet.
- Ethinyl estradiol – 0.03 mg (30 micrograms) per tablet.
- Excipients: Other inactive ingredients (tablet core and coating excipients) are present but detailed composition is not available in the provided information.
Dosage & Administration / How to Use:
- Standard dose: Take 1 tablet orally once daily at the same time each day, with or without food, as directed by your doctor.
- Each blister pack contains 21 active tablets. Take 1 tablet daily for 21 consecutive days, followed by a 7-day tablet-free interval during which withdrawal bleeding usually occurs.
- Start of first pack (no previous hormonal contraception in the last month): Usually start on day 1 of the menstrual cycle (first day of bleeding). Your doctor may advise an alternative start day with additional barrier protection for the first 7 days.
- Switching from another combined oral contraceptive: Take the first Mozanglic tablet the day after the last active tablet of the previous pack, following your doctor’s instructions.
- Missed dose: If a tablet is missed, follow the specific missed-pill instructions provided in the patient leaflet or as advised by your doctor or pharmacist. In general, missing tablets may reduce contraceptive effectiveness and may require additional barrier methods (e.g. condoms) for a certain period.
- Do not exceed the prescribed daily dose. Do not stop or change your regimen without consulting your healthcare provider.
Clinical Benefits:
- Provides highly effective hormonal contraception when taken correctly, significantly reducing the risk of unintended pregnancy.
- Prevents ovulation and thickens cervical mucus, making it more difficult for sperm to reach the uterus and for fertilization to occur.
- Induces changes in the endometrial lining, making implantation of a fertilized egg less likely.
- Helps regulate menstrual cycles, often resulting in more predictable and lighter periods.
- May reduce menstrual cramps and menstrual-related discomfort in many users.
- May improve acne and oily skin in some women, due to the anti-androgenic properties of drospirenone, when prescribed for this indication.
Warnings & Contraindications:
- Prescription-only medicine. Use only under the supervision of a qualified healthcare professional.
- Contraindicated in women with current or past venous thromboembolism (deep vein thrombosis, pulmonary embolism) or known thrombophilia.
- Contraindicated in women with a history of arterial thromboembolic events (e.g. myocardial infarction, stroke) or conditions predisposing to such events (e.g. severe hypertension, severe dyslipidemia).
- Contraindicated in women with known or suspected breast cancer or estrogen/progestin-dependent tumors.
- Contraindicated in women with severe liver disease, liver tumors, or unexplained jaundice; do not use in presence of active hepatitis or significant hepatic impairment.
- Contraindicated in pregnancy or in women with known or suspected pregnancy. Not indicated during breastfeeding unless specifically advised by a doctor.
- Use with caution in women who smoke, especially those over 35 years, due to increased cardiovascular risk. Smoking cessation is strongly recommended.
- Use with caution in women with risk factors such as obesity, migraine (especially with aura), diabetes, hypertension, dyslipidemia, or a family history of thromboembolic disease.
- May increase the risk of blood clots, stroke, and heart attack, particularly in high-risk women. Seek immediate medical attention if you experience chest pain, sudden shortness of breath, severe headache, vision changes, or leg pain/swelling.
- Certain medicines (e.g. some antiepileptics, rifampicin, some HIV/HCV medicines, herbal preparations like St. John’s wort) may reduce contraceptive effectiveness. Inform your doctor about all medicines and supplements you are taking.
- Does not protect against HIV (AIDS) or other sexually transmitted infections (STIs). Use condoms for STI protection.
- Consult your doctor before use if you are breastfeeding, have liver disease, kidney disease, diabetes, migraines, depression, gallbladder disease, or any chronic medical condition.
- Keep out of reach of children.
Side Effects:
- Common side effects may include nausea, abdominal pain, breast tenderness, headache, mood changes, spotting or breakthrough bleeding, and changes in menstrual flow.
- Other possible side effects: weight changes, fluid retention, decreased libido or increased libido, mild skin changes (including acne improvement or, less commonly, worsening), and changes in blood pressure.
- Serious but less common side effects include venous or arterial thromboembolic events (blood clots), severe hypertension, liver problems, gallbladder disease, and severe allergic reactions.
- Stop taking the product and seek immediate medical attention if you experience symptoms such as sudden chest pain, shortness of breath, coughing blood, severe headache, vision or speech disturbances, sudden weakness or numbness on one side of the body, severe leg pain or swelling, or yellowing of the skin or eyes.
- If you notice any persistent, bothersome, or unusual symptoms, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at the temperature range specified on the package insert (exact temperature information is not available in the provided data; follow pack instructions).
Specifications:
- Form: Oral tablet.
- Strength per tablet: drospirenone 3 mg + ethinyl estradiol 0.03 mg.
- Pack size: 21 tablets per blister pack (21-day active tablet regimen).
- Intended use: Prescription hormonal contraceptive for women.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
